MEDALLION FINANCIAL CORP
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2026-06-30; filed 2026-08-05.
0001193125-26-335042
ITEM 1A. RISK FACTORSCurrent report: 10-Q
Period ended 2026-09-30; filed 2026-11-05.
0001193125-26-449774
ITEM 1A. RISK FACTORSThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 2 previous paragraphs and 2 current paragraphs.
1 unchanged; 1 reworded; 0 added; 0 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
The current filing states there were no material changes to risk factors.
This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.
Current filing’s statement
There have been no material changes in our risk factors from those disclosed in Part 1, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which was filed with the Securities and Exchange Commission on March 10, 2026.
Reworded paragraphs (1)
Previous wording
On April 29, 2022, our board of directors authorized a new stock repurchase program with no expiration date, pursuant to which we were authorized to repurchase up to $35 million of our shares, which was increased to $40 million on August 10, 2022, also with no expiration date. During the three months ended June 30, 2026, we repurchased 779,799 shares of our common stock at an aggregate price of $7.7 million. Accordingly, as of June 30, 2026, up to $6,722,239 of shares remained authorized for repurchase under our stock repurchase program.
Current wording
On April 29, 2022, our board of directors authorized a new stock repurchase program with no expiration date, pursuant to which we were authorized to repurchase up to $35 million of our shares, which was increased to $40 million on August 10, 2022, also with no expiration date. During the three months ended September 30, 2026, we repurchased 483,871 shares of our common stock at an aggregate price of $5.6 million. Accordingly, as of September 30, 2026, up to $1,166,647 of shares remained authorized for repurchase under our stock repurchase program, all of which was utilized in October 2026. On October 27, 2026, our board of directors approved a new stock repurchase plan with no expiration date, pursuant to which we are authorized to repurchase up to $40 million of our shares.